|
Cognitive
| Date |
Type |
Disease |
Title |
|
Aug 18, 2008 |
Chat |
CFIDS&FM |
Letters From Our Readers - Comments & Suggestions 08-20-08
Letters From Our Readers - Comments & Suggestions 08-20-08 |
|
Aug 17, 2008 |
Article,ClinicalTrial,Events |
CFIDS&FM |
E-mail Based Study of Neuroliminal (Mind-Body) Training for Chronic Fatigue Syndrome Now Recruiting
Individuals with ME/CFS are invited to participate in this study of an intriguing mind-body technique whose effects in other conditions such as depression and ADHD the developer compares to those of EEG biofeedback. |
|
Aug 14, 2008 |
Abstract |
CFIDS&FM |
Disruption of Cognitive function in Fibromyalgia Syndrome – Source: Pain, Aug 6, 2008
Detailed testing demonstrates impaired Cognitive function in FM patients vs. controls, identifies disrupted working memory as mechanism in the impairment, associates pain level with the disruption, but not sleep or mood differences. [Source: Pain, Aug 6, 2008] |
|
Aug 14, 2008 |
Abstract |
CFIDS&FM |
The combined effects of L-theanine and caffeine on Cognitive performance and mood. - Source: Nutritional Neuroscience, Aug 2008
Research replicates previous evidence suggesting that in combination caffeine and L-theanine – an amino acid known for ability to enter the brain and support reduced mental & physical stress/relaxation - support improvements in speed, accuracy, and focus in Cognitively demanding tasks that are superior to improvements achieved with caffeine alone. It’s a combo most commonly found in green tea. - Source: Nutritional Neuroscience, Aug 2008. |
|
Aug 13, 2008 |
Article,DrugNews,ClinicalTrial,Events |
CFIDS&FM |
Two new experimental Alzheimer’s drug trials now recruiting patient/caregiver teams in the U.S. – One in 30 locations and one in 28 locations
Target participation: more than 650 patients with diagnosis of probable Alzheimer’s or (for the second trial only) memory problems that may be a sign of Alzheimer’s. |
|
Aug 12, 2008 |
Abstract |
CFIDS&FM |
Association of Duration and Severity of Diabetes Mellitus with Mild Cognitive Impairment - Source: Archives of Neurology, August 2008
Mayo study of a population ages 70 to 89 suggests an association of mild Cognitive impairment (a transitional stage between normal aging & dementia) with earlier onset, longer duration, and greater severity of diabetes. [Source: Archives of Neurology, August 2008] |
|
Aug 06, 2008 |
Abstract |
CFIDS&FM |
Similarities in stress physiology among patients with chronic pain and headache disorders: Evidence for a common pathophysiological mechanism? - Source: The Journal of Headache and Pain, June 2008
Tension-type headache, fibromyalgia and chronic shoulder/neck pain patients appear to have similar physiological responses to & recovery from low-grade Cognitive stress, that set them apart from episodic pain conditions such as migraine. [Source: The Journal of Headache and Pain, June 2008] |
|
Aug 04, 2008 |
Abstract |
CFIDS&FM |
What initiates the formation of senile plaques? The origin of Alzheimer-like dementias in capillary hemorrhages - Source: Medical Hypotheses, Sep 2008
The proposal that plaques form at the sites of bleeding from the brain's tiny blood vessels explains many things: e.g., why oxidative stress/cardiovascular disease are associated with Alzheimer's, why antioxidants and other vascular-protective factors protect against dementia. [Source: Medical Hypotheses, Sep 2008 ] |
|
Jul 26, 2008 |
Article |
CFIDS&FM |
Dr. Fortanasce Explains the Alzheimer's Disease Crisis and a Protocol to Prevent or Delay It - at Any Age
Alzheimer's doctor and innovator Vincent Fortansce, MD (author of The Anti-Alzheimer's Prescription) provides useful information on Alzheimer's and its diagnosis, his view that a cure is unlikely any time soon, and the science-based protocol he recommends to prevent or delay the disease. |
|
Jul 25, 2008 |
Article,ClinicalTrial,Events |
CFIDS&FM |
Long-Term Study of Medication for Adults with ADHD – recruiting 1,925 subjects in 29 states, 18 countries, 150 centers
This long-term Phase III trial is recruiting only adults - ages 18 to 50 of both genders - who meet diagnostic criteria for ADHD. It will test sustained response to the nonstimulant SNRI drug atomoxetine over a year. |
|
|
Next 10 Articles>> |
|
|
|
